Cargando…

Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity

Laquinimod is a novel oral drug that is currently being evaluated for the treatment of relapsing-remitting (RR) multiple sclerosis (MS). Using the animal model for multiple sclerosis, experimental autoimmune encephalomyelitis (EAE), we examined how laquinimod promotes immune modulation. Oral laquini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schulze-Topphoff, Ulf, Shetty, Aparna, Varrin-Doyer, Michel, Molnarfi, Nicolas, Sagan, Sharon A., Sobel, Raymond A., Nelson, Patricia A., Zamvil, Scott S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316495/ https://www.ncbi.nlm.nih.gov/pubmed/22479444 http://dx.doi.org/10.1371/journal.pone.0033797

Ejemplares similares

Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression
por: Varrin-Doyer, Michel, et al.
Publicado: (2016)

Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity
por: Schulze-Topphoff, Ulf, et al.
Publicado: (2013)

MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies
por: Molnarfi, Nicolas, et al.
Publicado: (2013)

Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE
por: Shetty, Aparna, et al.
Publicado: (2014)

MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS
por: Varrin-Doyer, Michel, et al.
Publicado: (2014)

Aquaporin 4-Specific T Cells in Neuromyelitis Optica Exhibit a Th17 Bias and Recognize Clostridium ABC Transporter
por: Varrin-Doyer, Michel, et al.
Publicado: (2012)

B‐cell very late antigen‐4 deficiency reduces leukocyte recruitment and susceptibility to central nervous system autoimmunity
por: Lehmann‐Horn, Klaus, et al.
Publicado: (2015)

Laquinimod, a prototypic quinoline-3-carboxamide and aryl hydrocarbon receptor agonist, utilizes a CD155-mediated natural killer/dendritic cell interaction to suppress CNS autoimmunity
por: Ott, Martina, et al.
Publicado: (2019)

Gut microbiome analysis in neuromyelitis optica reveals overabundance of Clostridium perfringens
por: Cree, Bruce A. C., et al.
Publicado: (2016)

Glatiramer acetate treatment negatively regulates type I interferon signaling
por: Molnarfi, Nicolas, et al.
Publicado: (2015)

CAR-T Cell–Mediated B-Cell Depletion in Central Nervous System Autoimmunity
por: Gupta, Sasha, et al.
Publicado: (2023)

N-(Quinolin-8-yl)quinoline-2-carboxamide
por: Li, Yanfeng, et al.
Publicado: (2012)

Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model
por: Wilmes, Anna T., et al.
Publicado: (2018)

Aryl Hydrocarbon Receptor Activation in Astrocytes by Laquinimod Ameliorates Autoimmune Inflammation in the CNS
por: Rothhammer, Veit, et al.
Publicado: (2021)

Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells
por: Dobson, Lucianne, et al.
Publicado: (2016)

Immunodominant T Cell Determinants of Aquaporin-4, the Autoantigen Associated with Neuromyelitis Optica
por: Nelson, Patricia A., et al.
Publicado: (2010)

Crystal structure of N-hydroxyquinoline-2-carboxamide monohydrate
por: Safyanova, Inna S., et al.
Publicado: (2017)

Laquinimod Inhibits Inflammation-Induced Angiogenesis in the Cornea
por: Li, Zuohong, et al.
Publicado: (2020)

Laquinimod Supports Remyelination in Non-Supportive Environments
por: Nyamoya, Stella, et al.
Publicado: (2019)

N-(Quinolin-8-yl)ferrocene-1-carboxamide
por: Li, Xia, et al.
Publicado: (2011)

Crystal structure of benzo[h]quinoline-3-carboxamide
por: Grathwol, Christoph W., et al.
Publicado: (2019)

Laquinimod Therapy in Multiple Sclerosis: A Comprehensive Review
por: Kolb-Sobieraj, Channa, et al.
Publicado: (2014)

A phase II study of laquinimod in Crohn's disease
por: D'Haens, Geert, et al.
Publicado: (2015)

Laquinimod treatment in the R6/2 mouse model
por: Ellrichmann, Gisa, et al.
Publicado: (2017)

N-Isopropyl-6-methyl-2-phenylquinoline-3-carboxamide
por: Benzerka, Saida, et al.
Publicado: (2010)

Investigating the Spectrum of Biological Activity of Substituted Quinoline-2-Carboxamides and Their Isosteres (†)
por: Gonec, Tomas, et al.
Publicado: (2012)

Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
por: Björk, Per, et al.
Publicado: (2009)

Laquinimod in the treatment of multiple sclerosis: a review of the data so far
por: Thöne, Jan, et al.
Publicado: (2016)

Crystal structures of three N-(3-acetylphenyl)quinoline-2-carboxamides
por: Peña-Solórzano, Diana, et al.
Publicado: (2017)

Crystal structure of N-(2-benzoyl-5-ethynylphenyl)quinoline-2-carboxamide
por: Peña-Solórzano, Diana, et al.
Publicado: (2017)

Synthesis, characterization and in vitro antitrypanosomal activities of new carboxamides bearing quinoline moiety
por: Ugwu, David Izuchukwu, et al.
Publicado: (2018)

Quinoline-3-carboxamide Derivatives as Potential Cholesteryl Ester Transfer Protein Inhibitors
por: Li, Wen-Yan, et al.
Publicado: (2012)

Laquinimod reduces neuroaxonal injury through inhibiting microglial activation
por: Mishra, Manoj Kumar, et al.
Publicado: (2014)

Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake
por: Gentile, Antonietta, et al.
Publicado: (2018)

The Change of Fingolimod Patient Profiles over Time: A Descriptive Analysis of Two Non-Interventional Studies PANGAEA and PANGAEA 2.0
por: Ziemssen, Tjalf, et al.
Publicado: (2021)

Derivatives of 6-cinnamamido-quinoline-4-carboxamide impair lysosome function and induce apoptosis
por: Kuo, Hsiao-Hui, et al.
Publicado: (2016)

Author Correction: Laquinimod treatment in the R6/2 mouse model
por: Ellrichmann, Gisa, et al.
Publicado: (2019)

T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity
por: Sagan, Sharon A., et al.
Publicado: (2023)

Synthesis and biological evaluation of novel 8-substituted quinoline-2-carboxamides as carbonic anhydrase inhibitors
por: Thacker, Pavitra S., et al.
Publicado: (2019)

Laquinimod prevents cuprizone-induced demyelination independent of Toll-like receptor signaling
por: Kramann, Nadine, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gmt99mgqh8ad2vqi5bsfnea1jl